Amaç: Bu çalışmada kalp cerrahisi yapılan hastalarda eşlik eden argon bazlı kriyoablasyonun orta dönem sonuçları sunuldu.
Surgical ablation for atrial fibrillation (AF) has been under continuous development for more than three decades and is recommended at the time of concomitant cardiac operations to restore sinus rhythm (SR). [1] Despite good progress in the management of patients with AF, this arrhythmia remains one of the major causes of stroke, heart failure, sudden death, and cardiovascular morbidity worldwide. The Cox Maze III procedure is a precisely defined pattern of biatrial incisions to eliminate AF in patients undergoing open cardiac surgery. The reported SR conversion rate after the Cox-Maze III procedure is 97 to 99% and is, therefore, considered the golden standard. [2] However, due to its technical difficulty, only a few surgeons performed this procedure. Over the years, application of various energy sources such as radiofrequency or cryothermy and lesion sets have been used to create lines of conduction block, replacing the suture lines of the classic approach. [3] [4] [5] [6] As a treatment for AF, the CryoMaze procedure creates linear frozen scars in the upper chamber of the heart by applying an Argonpowered cold probe to freeze the tissue. By freezing the tissue to very cold temperatures and creating electrical obstacles, electrical activity is permanently obstructed. [3, 6, 7] In the present study, we aimed to present midterm results of isolated left atrial (LA) or biatrial cryoablation technique for the treatment of AF as a concomitant procedure of open cardiac surgery and to report a structured local follow-up to one year postoperatively.
PATIENTS AND METHODS
This prospective, single-center study included a total of 33 patients (17 males, 16 females; mean age 63.9 years; range 45 to 82 years) who underwent open cardiac surgery concomitant endocardial cryoablation for the treatment of AF between August 2014 and May 2016. The demographic characteristics of the patients are presented in Table 1 . The study protocol was approved by the ethics committee. An informed consent was obtained from each patient. The study was conducted in accordance with the principles of the Declaration of Helsinki.
Perioperative data were retrieved from the institutional database. Preoperative AF was defined as intermittent (paroxysmal, persistent) or permanent according to the Heart Rhythm Society/European Heart Rhythm Association/European Cardiac Arrhythmia Society. Additional rhythm related data were collected including presence of AF at the time of surgery, duration of AF, antiarrhythmic medications, and echocardiographic data such as LA size and left ventricular ejection fraction were all retrieved from database.
There was a heterogeneity for the type of procedures and the approach in terms of robotic assistance; however, uniform protocol for ablation and lesion set was used in all patients. If the LA was planned to open alone (n=24), this was achieved through interatrial groove following midsternal approach and central cannulation (ascending aorta and bicaval) in non-robotic assisted patients. The LA appendage was ligated in all patients using a double layered running suture from the inside of LA. Cryoablation was performed using a flexible argon-based device (cryoICE cryoablation probe, AtriCure Inc., West Chester, OH, USA; Cardioblate CryoFlex Surgical Ablation Probe, Medtronic Inc., Minneapolis, MN, USA) and starting with an ablation line extending from the atriotomy to the mitral valve annulus in the region P2/P3. The left and right pulmonary veins were isolated, an inferior and superior ablation line was placed to complete the box lesion for isolation of the posterior atrial wall, and an additional lesion was placed to connect the box to the closure line of the LA appendage. The cryoprobe can be fit to the shape of the atrial wall, either endocardial or epicardial, creating cryolesions of 1 to 10 cm in length. Principally, atrial cryolesions in this series were performed for 90 sec reaching local temperatures of -130°C. Biatrial ablation (n=9, 27.2%) was performed in the patients with atrial flutter or enlarged right atrium (RA) such as existence of atrial septal defect. An additional RA lesion set consisted of an intercaval lesion extending from the superior vena cava (SVC) to the inferior vena cava (IVC); from this lesion to tricuspid valve annulus and finally from the first lesion to RA appendage. Twenty-four of the patients (72.7%) underwent mitral valve surgery. The types of the concomitant surgeries in addition to LA or biatrial cryoablation were summarized in Table 2 .
Robotic assistance was used in 12 patients, and the operative technique was detailed previously. [8] Briefly, in robotic approach, cardiopulmonary bypass (CPB) was achieved via peripheral cannulation (femoral artery, femoral vein, internal jugular vein) under guidance of transesophageal echocardiography (TEE). The heart was arrested using cold crystalloid cardioplegia delivered into the aortic root with a transthoracic cannula through the thoracotomy. The inferior and superior venae cavae were occluded with bulldog clamps in patients which the RA was opened. The cryoprobe is flexible and also suitable for creating ablation during robotic assistance.
The mean duration of follow-up was 18 (range 10 to 30) months among the discharged patients. Follow-up data were 100% complete for all patients, and no patients died during this period.
All patients received oral anticoagulation therapy with warfarin for three months regardless of postoperative rhythm. The continuation of oral anticoagulation therapy was decided according to the CHA2DS2-VASc score. The patients with mechanical valves received life-long anticoagulation. All patients were treated with b-blockers and amiodarone after surgery, unless postoperative bradycardia or junctional rhythm was detected.
Prospective follow-up protocol was started in August 2014, consisting of outpatient visits to the responsible surgeon at first month. The rhythm assessment with 12-lead electrocardiography (ECG) and 24-h Holter, and recordings of AF-related medication, stroke, or other thromboembolic events were evaluated by the cardiologist at three and 12 months, postoperatively. Definition of success for these patients was normal sinus or pacing rhythm, and freedom from AF at discharge and during follow-up. The patients were classified as free from AF, when they were in sinus rhythm, atrial paced without underlying AF, junctional rhythm or other regular rhythm. The patients who developed AF or atrial flutter, and those who were paced, but had underlying AF were classified as AF patients. The failure of the cryoablation procedure was defined as AF more than three months following the procedure. 
Statistical analysis
For the statistical analysis, the program NCSS (Number Cruncher Statistical System) 2007 Statistical Software (NCSS LLC, Kaysville, Utah, USA) (License No: 1675948377483; Serial No: N7H5-J8E5-D4G2-H5L6-W2R7) was used. The mean, standard deviation, minimum, maximum, range, median, frequency and ratio calculations from the descriptive statistical methods were used when the descriptive study data were evaluated.
RESULTS
Two patients (6%) had paroxysmal and 31 (94%) had persistent AF before operation. The mean duration of AF was 38.5 (range, 1 to 180) months, this was 36.6 (range, 14 to 60) months in recurrent AF group and 38.7 (range, 1 to 180) months in the treated AF group. The mean LA size was 50 mm (range, 39 to 68) mm. The mean CPB and mean cross-clamp time was 140.7 (range, 91 to 217) min and 99.5 (range, 31 to 171) min, respectively.
Cryoablation failed in three patients (n=2, 8.3 % in isolated LA and n=1, 11.1% in biatrial group) following the operation in the mid-term. Thirty patients (90.9%) were in sinus rhythm and three (9.1%) were in AF at the time of discharge. One of them became AF in the treated group and required permanent pacemaker implantation following cardioversion; however, this patient maintained sinus rhythm in the follow-up. One more patient required a permanent pacemaker implantation in the failure group due to slow-transition AF. During follow-up, 30 patients (90.9%) maintained their sinus rhythm. The patients with permanent AF at the time of surgery (n=31, 94%) had an increased rate of recurrence at discharge (n=3, 9.1%), compared to those with intermittent AF (n=0.0%).
The LA was larger than 55 mm in 1/3 (33.3%) of failure patients; however, by cryoablation 6/7 (85.7%) patients were converted to sinus rhythm among the patients who had LA larger than 55 mm.
Among the patients, there was no in-hospital mortality and no major postoperative complications such as stroke, sepsis, renal failure requiring dialysis, and prolonged respiratory failure.
DISCUSSION
Our results show that surgical cryoablation is an effective method for the treatment of AF, when performed concomitantly with other cardiac surgical procedures. This technique resulted in low AF recurrence rates in the mid-term follow-up (3/33; 9.1%).
There is a very limited number of studies showing the results of cryoablation procedure with robotic assistance in the literature. [9] With the use of specialized robotic forceps, the probe can be molded to conform geometrically to an individual atrial anatomy. In our study, 12 patients underwent cryoablation with robotic assistance and 11 of them converted to sinus rhythm in the mid-term follow-up. The combination of dynamic LA retraction, improved dexterity using endowrist technology, and three-dimensional vision allows surgeon for precise placement of the cryoprobe and avoidance of skips caused by folds in the floor of the LA.
When analyzing the results, creating LA lesions in the setting of more chronic AF (long-lasting persistent AF) seems to be less effective, and these patients may derive greater benefit from a more extensive ablation procedure, such as creating biatrial lesion.
Our findings were consistent with Charitos et al. [10] suggesting that the preoperative duration of AF and the use of a box lesion only in patients with longer AF persistence history were independently associated with higher postoperative AF burden recurrence and many patients later required repeated catheter ablation interventions or the need for electrical cardioversion. In a study containing a large number of patients (n=503) with nine years period of observation, the statistically significant predictors for sinus rhythm continuation after one year were LA diameter, AF duration, preoperative paroxysmal AF, immediate postoperative sinus rhythm, and biatrial ablation for persistent AF. [11] Our data showed that even in patients with large LA diameters, concomitant surgical AF ablation may restore sinus rhythm with negligible AF recurrence up to one year postoperatively, and enlarged LA diameters should not be considered as a contraindication for concomitant surgical ablation of AF.
The correction of severe mitral valve regurgitation was associated with lower AF burdens during the total observation period. In a similar manner, the patients with mild to moderate mitral valve regurgitation who did not undergo mitral valve repair had significantly higher AF burden during follow-up. [10] Similar conclusions have been obtained after catheter ablation which underscores the influence of coexisting mitral regurgitation on the outcomes of AF ablation procedures. In the case of the surgical patient, correction of mild-tomoderate mitral regurgitation in patients undergoing concomitant surgical AF ablation leads to lower rates of AF recurrence and should be strongly considered. [10] On the other hand, due to the small number of patients and the resulting limited statistical power, none of the randomized trials was able to show a survival benefit for patients receiving concomitant ablation. However, in a recent propensity scorematched analysis by McCarthy et al., [12] the mid-term survival of patients with AF receiving concomitant surgical ablation was statistically significantly higher, compared to the untreated patients and comparable to those of patients without preoperative AF.
There are several limitations of the present study, such as a non-randomized retrospective study design with a limited number of patients. Furthermore, the present study was a single center analysis, consisting of a wide spectrum of patients undergoing open cardiac surgery.
In conclusion, our study results suggest that the surgical treatment of atrial fibrillation using this flexible argon-based cryoablation device was safe and effective during a wide variety of concomitant cardiac procedures. This procedure takes 10 to 20 min which does not significant prolong the cardiopulmonary bypass duration. On the basis of our findings, all patients with any history of atrial fibrillation undergoing a cardiac surgical procedure may be considered for a concomitant ablation procedure.
